Literature DB >> 26221754

Comorbidity as a driver of adverse outcomes in people with chronic kidney disease.

Marcello Tonelli1, Natasha Wiebe2, Bruce Guthrie3, Matthew T James1, Hude Quan4, Martin Fortin5, Scott W Klarenbach2, Peter Sargious6, Sharon Straus7, Richard Lewanczuk6, Paul E Ronksley4, Braden J Manns1, Brenda R Hemmelgarn1.   

Abstract

Chronic kidney disease (CKD) is associated with poor outcomes, perhaps due to a high burden of comorbidity. Most studies of CKD populations focus on concordant comorbidities, which cause CKD (such as hypertension and diabetes) or often accompany CKD (such as heart failure or coronary disease). Less is known about the burden of mental health conditions and discordant conditions (those not concordant but still clinically relevant, like dementia or cancer). Here we did a retrospective population-based cohort study of 530,771 adults with CKD residing in Alberta, Canada between 2003 and 2011. Validated algorithms were applied to data from the provincial health ministry to assess the presence/absence of 29 chronic comorbidities. Linkage between comorbidity burden and adverse clinical outcomes (mortality, hospitalization or myocardial infarction) was examined over median follow-up of 48 months. Comorbidities were classified into three categories: concordant, mental health/chronic pain, and discordant. The median number of comorbidities was 1 (range 0-15) but a substantial proportion of participants had 3 and more, or 5 and more comorbidities (25 and 7%, respectively). Concordant comorbidities were associated with excess risk of hospitalization, but so were discordant comorbidities and mental health conditions. Thus, discordant comorbidities and mental health conditions as well as concordant comorbidities are important independent drivers of the adverse outcomes associated with CKD.

Entities:  

Mesh:

Year:  2015        PMID: 26221754     DOI: 10.1038/ki.2015.228

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

1.  The James Lind Alliance: tackling research mismatches.

Authors:  Sophie Petit-Zeman; Lester Firkins; John W Scadding
Journal:  Lancet       Date:  2010-08-28       Impact factor: 79.321

2.  Health burden in chronic disease: multimorbidity is associated with self-rated health more than medical comorbidity alone.

Authors:  Anthony V Perruccio; Jeffrey N Katz; Elena Losina
Journal:  J Clin Epidemiol       Date:  2011-08-10       Impact factor: 6.437

3.  Use and misuse of population attributable fractions.

Authors:  B Rockhill; B Newman; C Weinberg
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

Review 4.  Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice.

Authors:  Nathan D Shippee; Nilay D Shah; Carl R May; Frances S Mair; Victor M Montori
Journal:  J Clin Epidemiol       Date:  2012-10       Impact factor: 6.437

5.  The treatment of unrelated disorders in patients with chronic medical diseases.

Authors:  D A Redelmeier; S H Tan; G L Booth
Journal:  N Engl J Med       Date:  1998-05-21       Impact factor: 91.245

Review 6.  Multimorbidity is common to family practice: is it commonly researched?

Authors:  Martin Fortin; Lise Lapointe; Catherine Hudon; Alain Vanasse
Journal:  Can Fam Physician       Date:  2005-02       Impact factor: 3.275

7.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

8.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

Authors:  Karen Barnett; Stewart W Mercer; Michael Norbury; Graham Watt; Sally Wyke; Bruce Guthrie
Journal:  Lancet       Date:  2012-05-10       Impact factor: 79.321

9.  Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidity.

Authors:  Martin Fortin; Eric Contant; Catherine Savard; Catherine Hudon; Marie-Eve Poitras; José Almirall
Journal:  BMC Fam Pract       Date:  2011-07-13       Impact factor: 2.497

10.  Patterns of physical co-/multi-morbidity among patients with serious mental illness: a London borough-based cross-sectional study.

Authors:  Charlotte Woodhead; Mark Ashworth; Peter Schofield; Max Henderson
Journal:  BMC Fam Pract       Date:  2014-06-11       Impact factor: 2.497

View more
  69 in total

1.  We Need to Train the Trainers.

Authors:  Arif Asif; Gerald A Beathard
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-25       Impact factor: 8.237

Review 2.  Physical inactivity: a risk factor and target for intervention in renal care.

Authors:  Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis
Journal:  Nat Rev Nephrol       Date:  2017-01-31       Impact factor: 28.314

3.  Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.

Authors:  Paul E Ronksley; Brenda R Hemmelgarn; Braden J Manns; James Wick; Matthew T James; Pietro Ravani; Robert R Quinn; Nairne Scott-Douglas; Richard Lewanczuk; Marcello Tonelli
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-06       Impact factor: 8.237

4.  Fast GFR decline and progression to CKD among primary care patients with preserved GFR.

Authors:  Farrukh M Koraishy; Denise Hooks-Anderson; Joanne Salas; Michael Rauchman; Jeffrey F Scherrer
Journal:  Int Urol Nephrol       Date:  2018-02-05       Impact factor: 2.370

5.  A Novel Approach to Developing a Discordance Index for Older Adults With Chronic Kidney Disease.

Authors:  Rasheeda K Hall; Hui Zhou; Kristi Reynolds; Teresa N Harrison; C Barrett Bowling
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-02-14       Impact factor: 6.053

6.  Multimorbidity, dementia and health care in older people:a population-based cohort study.

Authors:  Marcello Tonelli; Natasha Wiebe; Sharon Straus; Martin Fortin; Bruce Guthrie; Matthew T James; Scott W Klarenbach; Helen Tam-Tham; Richard Lewanczuk; Braden J Manns; Hude Quan; Paul E Ronksley; Peter Sargious; Brenda Hemmelgarn
Journal:  CMAJ Open       Date:  2017-08-14

7.  Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD.

Authors:  Germaine Wong; Jade S Hayward; Eric McArthur; Jonathan C Craig; Danielle M Nash; Stephanie N Dixon; Deborah Zimmerman; Abhijat Kitchlu; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-29       Impact factor: 8.237

8.  Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular Hypertension.

Authors:  Dong Sun; Zhi Chen; Alfonso Eirin; Xiang-Yang Zhu; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2016-01-05       Impact factor: 2.689

Review 9.  Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.

Authors:  Jiahua Li; Oltjon Albajrami; Min Zhuo; Chelsea E Hawley; Julie M Paik
Journal:  Clin J Am Soc Nephrol       Date:  2020-06-09       Impact factor: 8.237

10.  Use of Potentially Nephrotoxic Medications by U.S. Adults with Chronic Kidney Disease: NHANES, 2011-2016.

Authors:  Shaheen Kurani; Molly Moore Jeffery; Bjorg Thorsteinsdottir; LaTonya J Hickson; Erin F Barreto; Jordan Haag; Rachel Giblon; Nilay D Shah; Rozalina G McCoy
Journal:  J Gen Intern Med       Date:  2019-12-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.